Skip to main content
Signal8

Prenetics Global Ltd (PRE) Form 6-K — Nov 18, 2026

$PREForm 6-KFiled Nov 18, 2026, 8:06 AM ET0001628280-26-074651Original filing

Prenetics Global (PRE) reported Q3 2026 revenue of $64.1 million, above its $63-64 million guidance and up roughly 228% year over year, with IM8 contributing $62.9 million in its seventh consecutive record quarter. September alone generated $23.7 million of IM8 revenue, an annualized run-rate of about $284 million. The bearish offset: management widened second-half Adjusted EBITDA loss guidance to $30-35 million from the $8-12 million guided in August, a deliberate choice to step up customer acquisition spending, 70% of qualifying spend financed by the $1 billion General Catalyst facility.

Key figures

Revenue
64112000
Guidance
FY2026 total revenue $220-230M (reaffirmed); H2 2026 Adjusted EBITDA loss revised to $30-35M from $8-12M; FY2027 IM8 revenue $400M+ (reaffirmed); year-end 2026 IM8 ARR $300M+
Total Debt
34678000
Revenue Yoy
~228% YoY growth (~3.3x)
Total Assets
172871000
Cash Position
111500000
Shares Outstanding
17477654
Gross margin
~64%
Im8 revenue q3
$62.9M (+~266% YoY)
Cvf net fundings q3
$31.6M
Active subscriptions
~160,000
September im8 revenue
$23.7M
Contribution profit q3
$30.6M (48% margin)
Adjusted ebitda loss q3
-$12.7M (20% of revenue vs 39% in Q2)
Customer acquisition cost
~$285 (from ~$301 in Q2)
Adjusted free cash flow q3
+$4.1M
Annualized revenue run rate
~$284M
General catalyst commitment
$1 billion

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.